EphA7 promotes contact-dependent myogenesis
EphA7促进接触依赖性肌生成
基本信息
- 批准号:10672896
- 负责人:
- 金额:$ 32.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-17 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdhesionsAdultAnimalsBindingBiologyBirthCell Culture TechniquesCell Differentiation processCell membraneCell physiologyCell surfaceCellsCephalicCommunitiesDataDevelopmentDevelopmental ProcessDifferentiation AntigensEmbryoEph Family ReceptorsEphrin-A5EphrinsEpigenetic ProcessExhibitsExposure toExtracellular DomainFiberGenetic TranscriptionGiant CellsHindlimbHumanHypertrophyIn VitroIndividualInjuryLeadLifeLigandsLinkMapsMediatingMediatorMembraneModelingMolecularMusMuscleMuscle CellsMuscle DevelopmentMuscle FibersMuscle satellite cellMyoblastsMyogeninNatural regenerationNeural Tube ClosurePhenotypePopulationProcessProliferatingProteinsReceptor Protein-Tyrosine KinasesRegenerative MedicineResistanceRoleSerumSignal TransductionSignal Transduction PathwaySignaling MoleculeSkeletal MuscleSurfaceTestingTissue DifferentiationTissue EngineeringTissuesVertebratesWorkadverse outcomedensityexperimental studyfetalin vivoin vivo regenerationinnovationinsightmembermuscle formmuscle regenerationmuscle strengthmyogenesispostnatalprecursor cellpreventprotein protein interactionreceptorrepairedretinal axonsatellite cellstem cell expansiontranscription factortranslational applications
项目摘要
SUMMARY
The conversion of proliferating skeletal muscle precursors (myoblasts) to terminally-differentiated myocytes
is a critical step in skeletal muscle development and repair; control of this process is therefore of
fundamental importance in both muscle development and muscle regeneration after injury. The tendency for
myogenic cells cultured densely to differentiate and, conversely, the resistance to differentiation of cells at
low density has been called the 'Community Effect'; understanding this phenomenon represents a basic
question in muscle biology. Based on our initial observation that EphA7, a juxtacrine signaling molecule, is
expressed on myocytes during embryonic and fetal myogenesis and on nascent myofibers during muscle
regeneration in vivo we examined the muscle phenotype of EphA7-/- mice. We found that their hindlimb
muscles possess fewer myofibers at birth, and those myofibers are reduced in size and have fewer
myonuclei and reduced overall numbers of precursor cells throughout postnatal life. Adult EphA7-/- mice
have reduced numbers of satellite cells and exhibit delayed and protracted muscle regeneration, and
satellite cell-derived myogenic cells from EphA7-/- mice are delayed in their expression of differentiation
markers in vitro. Exposure to exogenous EphA7 extracellular domain will rescue the null phenotype, and will
also accelerate commitment to differentiation in WT cells, which led us to propose a model in which EphA7
expression on differentiated myocytes promotes commitment of adjacent myoblasts to terminal
differentiation via reverse signaling. The experiments we propose in Aims 1 and 2 will address the role of
EphA7 in myogenic commitment in both the myocyte ("How does commitment to differentiation lead to
expression of EphA7?") and the myoblast ("How does receiving an EphA7 signal lead to commitment to
differentiation?"). Once they have differentiated, myocytes must fuse with each other or with a growing
myotube in order to generate a functional muscle cell (the contractile myocyte fiber), thus this also
represents a critical process in both development and regeneration. However, the molecular requirements
for fusion in mammalian muscle cells have been elusive. Our data suggest EphA7 also promotes myogenic
fusion, possibly via different molecular mechanisms/interactions from its role in promoting myogenic
differentiation. The experiments we propose in Aim 3 will test the ability of EphA7 to promote fusion in
myogenic and nonmyogenic cells, determine whether it associates with the cell-surface fusogen myomaker,
and identify other protein-protein interactions it is participating in at the interface of myocytes and growing
myotubes in cis (on the same cell membrane) or in trans (on opposing cell membranes). Collectively, these
studies will address the molecular mechanisms regulating two fundamental cellular processes during
myogenic differentiation; they also have the potential to provide insight into potential innovations in muscle
stem cell expansion in vitro and thus applications in tissue engineering and regenerative medicine.
总结
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Eph/Ephrin-Based Protein Complexes: The Importance of cis Interactions in Guiding Cellular Processes.
- DOI:10.3389/fmolb.2021.809364
- 发表时间:2021
- 期刊:
- 影响因子:5
- 作者:Cecchini A;Cornelison DDW
- 通讯作者:Cornelison DDW
Extracellular matrix: Brick and mortar in the skeletal muscle stem cell niche.
- DOI:10.3389/fcell.2022.1056523
- 发表时间:2022
- 期刊:
- 影响因子:5.5
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dawn D Cornelison其他文献
Dawn D Cornelison的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dawn D Cornelison', 18)}}的其他基金
Ex vivo expansion of skeletal muscle satellite cells
骨骼肌卫星细胞的离体扩增
- 批准号:
10570269 - 财政年份:2022
- 资助金额:
$ 32.63万 - 项目类别:
Ex vivo expansion of skeletal muscle satellite cells
骨骼肌卫星细胞的离体扩增
- 批准号:
10390539 - 财政年份:2022
- 资助金额:
$ 32.63万 - 项目类别:
Ephrin-A3 Specifies Slow Muscle Fiber Type
Ephrin-A3 指定慢肌纤维类型
- 批准号:
8923146 - 财政年份:2014
- 资助金额:
$ 32.63万 - 项目类别:
Ephrin-A3 specifies slow muscle fiber type
Ephrin-A3 指定慢肌纤维类型
- 批准号:
8810472 - 财政年份:2014
- 资助金额:
$ 32.63万 - 项目类别:
Soluble Motogens and Chemoattractants from Damaged Muscle
受损肌肉中的可溶性促动力剂和化学引诱剂
- 批准号:
8383029 - 财政年份:2012
- 资助金额:
$ 32.63万 - 项目类别:
Soluble Motogens and Chemoattractants from Damaged Muscle
受损肌肉中的可溶性促动力剂和化学引诱剂
- 批准号:
8500217 - 财政年份:2012
- 资助金额:
$ 32.63万 - 项目类别:
Molecular Mechanisms Regulating Motility and Migration of Muscle Satellite Cells
调节肌肉卫星细胞运动和迁移的分子机制
- 批准号:
7907839 - 财政年份:2009
- 资助金额:
$ 32.63万 - 项目类别:
Molecular mechanisms regulating motility and migration of muscle satellite cells
调节肌肉卫星细胞运动和迁移的分子机制
- 批准号:
7572440 - 财政年份:2009
- 资助金额:
$ 32.63万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 32.63万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 32.63万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 32.63万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 32.63万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 32.63万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 32.63万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 32.63万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 32.63万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 32.63万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 32.63万 - 项目类别:














{{item.name}}会员




